Pharmalinks

What Pharmalinks does

Pharmalinks UAB is a privately held pharmaceutical services company headquartered in Kaunas, Lithuania, with a secondary office in Tallinn, Estonia. Founded in 2019 by CEO Janno Kurg, who brings over a decade of experience leading pharmaceutical wholesalers across Estonia, Latvia, and Lithuania, the company is explicitly positioned as a strategic substitute for pharma multinational subsidiaries that choose not to enter or elect to exit the Baltic market. Pharmalinks delivers an integrated portfolio of eight service lines: sales and marketing services (medical representative deployment, key account management, brand strategy, digital marketing, campaign planning); market access services (pricing, reimbursement, HTA support, stakeholder mapping); wholesale distribution and warehousing; hospital and tender support; regulatory, compliance, and quality services; financial management and market analytics; clinical trials documentation support; and charity and probono activities focused on pediatric patient access.

Service delivery is conducted by a core team of five specialists — covering quality/operations, purchasing/sales, administration, and finance — supplemented by a partnership network of more than 15 experts drawn from across the Baltic pharmaceutical supply chain, including sales and marketing professionals, regulatory and PR specialists, market access and HTA experts, and therapy area leads. The business operates on professional services and transaction-fee revenue models, with pricing customized per client engagement and not publicly disclosed. Distribution infrastructure is delivered through partner arrangements: Oribalt UAB is the primary warehousing partner in Trakai, Lithuania, with Magnum Group and Tamro Baltics as additional recommended wholesale partners, and a second warehousing facility in Riga, Latvia. Customer-facing verticals include pharma multinational subsidiaries (enterprise), local pharmacy chains, wholesalers, healthcare professionals, hospitals and institutional buyers, and patient advocacy groups, with primary geographic focus on Estonia, Latvia, and Lithuania and stated secondary ambitions in the Nordic region and Central Europe.

The company is registered as Pharmalinks UAB in Lithuania (registration number 306735134) and holds no proprietary technology platform, API, or app; all services are human-delivered. No external funding rounds, M&A activity, or institutional investors are disclosed. The principal scale markers in the public record — a partner network generating over 75 million EUR in turnover and distributing more than 50,000 packages annually, and a market access team track record of 130+ successful reimbursement outcomes — describe the partner ecosystem and accumulated institutional capability rather than Pharmalinks' own revenue.

Name

Pharmalinks

Legal name

Pharmalinks UAB

Website

https://pharmalinks.eu

Company type

Private

Founded year

2019

Operating status

Operating

Short description

Pharmalinks provides sales, marketing, market access, and distribution services to pharmaceutical companies in the Baltic region, serving as a strategic substitute for multinational subsidiaries exiting the market. Operates with five specialists and a 15+ expert partner network.

Ownership category

akta.pro rank

Product category

Pharmaceutical Commercial Services

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Specialty Pharmaceutical Distributors (HLAIAJAB)

akta.pro secondary industry

Pharmacy Supply Chain & Secondary Distribution (Repackagers/Redistributors) (CRAOAHAC)

Keywords

• Pharmaceutical distribution services
• Pharma market access
• Pharmaceutical sales marketing
• Medical representative deployment
• Pharma wholesale warehousing

Headquarters

HQ city

Tallinn

HQ country

Estonia

HQ region

Europe

Offices4 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Sales and Marketing Services: Comprehensive marketing and sales services for pharmaceutical products including market access strategy, brand development, field force execution, medical representative deployment, key account management, product launch support, sales training, brand strategy, medical marketing, digital marketing, and campaign planning.
2. Market Access Services: Strategic partner in co-creation of integrated access strategies including pricing and reimbursement support, market access planning, health technology assessment support, and stakeholder mapping and engagement.
3. Wholesale Distribution Services: Wholesale distribution and warehousing services through partners including single channel distribution, pre-wholesale services, safety/emergency stock keeping, product labelling and packaging, extra quarantine, and home delivery.
4. Regulatory and Compliance Services: Ethical marketing practices, pharmacovigilance coordination, promotional compliance, destruction of expired medicines, documents handling, and product recall services.
5. Hospital and Tenders Services: Tender and institutional sales support, tenders data analysis, documentation handling, and clinical trials documentation handling.
6. Financial Management Services: Market research and analytics, sales reports from the Baltic Pharma market, and accounting services.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels3 records

Core offering

Pharmalinks provides commercial, marketing, market access, and distribution services for pharmaceutical products in the Baltic region, acting as a strategic substitute for pharma multinational subsidiaries that choose not to enter or elect to exit the Baltic market. Its offerings span sales and marketing, market access, wholesale distribution and warehousing, hospital and tender support, regulatory and quality services, financial management, and clinical trials support.

Product overview

Pharmalinks is a pharmaceutical sales and marketing services company serving as a strategic substitute for pharma multinational subsidiaries in the Baltic region. The company operates as a unified platform delivering integrated services across the pharmaceutical supply chain, consisting of eight core service offerings: Sales and Marketing Services of Pharmaceutical Products (including Medical Representative Deployment, Key Account Management, Channel & Distribution Support, Product Launch Support, Sales Training, Brand Strategy, Medical Marketing, Digital Marketing, and Campaign Planning); Go-to-Market Services for Incremental Value Creation (Market Access) providing pricing, reimbursement, and HTA support; Wholesale Distribution and Warehousing; Hospital and Tenders services; Regulatory, Compliance and Quality Services; Financial Management (Market Research, Sales Reports, Accounting); Clinical Trials Support; and Charity and Probono Activities. These services are delivered through an internal team of five specialists and a partnership network of over 15 experts.

Differentiator

Problem solved

Functional benefit

Products and services

• Sales and Marketing Services of Pharmaceutical Products Comprehensive marketing and sales services for pharmaceutical products supporting partners across the full product lifecycle, including market access strategy, brand development, field force execution, medical representative deployment, key account management, product launch support, sales training, brand strategy, medical marketing, digital marketing, and campaign planning. For pharmaceutical companies seeking commercial coverage in the Baltic region.
• Go-to-Market Services for Incremental Value Creation (Market Access) Strategic market access services covering pricing and reimbursement support, market access planning, health technology assessment (HTA) support, stakeholder mapping and engagement, advocacy programs, and KOL programs. Supports pharmaceutical companies preparing, submitting, and executing reimbursement dossiers in the Baltic region.
• Wholesale Distribution and Warehousing Wholesale distribution and warehousing services including single channel distribution, pre-wholesale services, safety/emergency stock keeping, product labelling and packaging, extra quarantine, and home delivery. Delivered via partner-led warehousing across the Baltic region to pharmaceutical principals and wholesalers.
• Hospital and Tenders Tender and institutional sales support services including tender data analysis, documentation handling, and clinical trials documentation handling. Serves pharmaceutical suppliers seeking to win and fulfil hospital and institutional contracts in the Baltic region.
• Regulatory, Compliance and Quality Services Services covering ethical marketing practices, pharmacovigilance coordination, promotional compliance, destruction of expired medicines, regulatory documents handling, and product recall handling. For pharmaceutical companies requiring local compliance oversight in the Baltic region.
• Financial Management Financial services supporting pharmaceutical clients, including market research and analytics, sales reports from the Baltic pharma market, and accounting services.
• Clinical Trials Support Clinical trials support delivered through a broad partner network of clinical trial customers, providing documentation handling and coordination for pharmaceutical sponsors operating in the Baltic region.

Quantifiable outcome

• 130+ successful reimbursement outcomes in the Baltic region
• +2 more outcomes

Named customers6 records

Segments5 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Eight partnerships are on record, tiered core and secondary.

• Oribalt UABcoreStrategic or Co-development PartnerPrimary warehousing partner providing high-quality warehousing services for pharmaceutical products. Located in Trakai, Lithuania. This is a key operational partnership for Pharmalinks' distribution capabilities.
• Magnum GroupsecondaryChannel Partner/ Reseller/ DistributorRecommended wholesale partner in the Baltic region. Serves as part of Pharmalinks' recommended distribution network for pharmaceutical products.
• Tamro BalticssecondaryChannel Partner/ Reseller/ DistributorRecommended wholesale partner in the Baltic region. Part of the recommended distribution network alongside Magnum Group.
• Clinical Trial Network PartnerssecondaryStrategic or Co-development PartnerPartners through which Pharmalinks maintains a broad network of Clinical Trial customers. Enables the company to offer clinical trials documentation handling services.
• Expert Network Partners (15+ Experts)coreStrategic or Co-development PartnerNetwork of over 15 experts from various sectors of the Baltic Pharma Supply Chain including Sales and Marketing professionals, Regulatory, PR, Market Access, Therapy Area Leads, HTA experts. These experts are engaged on a partnership basis and are essential to Pharmalinks' service delivery.
• Local Pharmacy Chains (Baltic Region)coreChannel Partner/ Reseller/ DistributorCollaboration with local pharmacy chains within the Baltic region for pharmaceutical product distribution and sales support.
• Healthcare Professionals NetworkcoreChannel Partner/ Reseller/ DistributorCollaboration with healthcare professionals within the Baltic region for product access and medical representative deployment services.
• Patient Advocacy GroupssecondaryOthersCollaboration with patient advocacy groups within the Baltic region, with special focus on improving access to innovative medicine for all Baltic patients, especially the youngest ones.

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Ewopharma: Specialty pharma commercialization platform for Central and Eastern Europe, offering market access, registration, sales, and distribution — the same value proposition Pharmalinks delivers, but in adjacent CEE territories.
• Oribalt UAB: Lithuanian pharmaceutical wholesaler that is Pharmalinks' primary warehousing partner; operates the same Baltic pharma distribution channel and is therefore both a partner and direct comparable.
• Tamro Baltics (Phoenix Group): Baltic pharmaceutical wholesaler and distribution partner listed in Pharmalinks' own network; operates in the same value chain of supplying pharma manufacturers to pharmacies and hospitals across the Baltics.
• Swixx Biopharma: Commercialization partner for biopharma companies across Central and Eastern Europe, providing market access, regulatory, sales, and distribution services — directly comparable to Pharmalinks' model but at larger CEE scale.
• Magnum Group: Baltic pharmaceutical wholesale and distribution group, named as a recommended wholesale partner of Pharmalinks — directly operates in the same Baltic pharma supply chain.
• Oriola Corporation: Nordic and Baltic healthcare distributor and pharmacy operator providing wholesale, dose dispensing, and advisory services — comparable regional pharma distribution footprint overlapping with Pharmalinks' Baltics reach.

Broad incumbents

• Krka: Slovenian-headquartered generic pharma manufacturer with strong Central and Eastern European distribution and market access operations — broader-scale incumbent operating overlapping CEE commercialization services.
• STADA Arzneimittel: European specialty and generics pharma company with broad CEE distribution and commercialization footprint — incumbent competitor for the same multinational client mandates Pharmalinks targets.
• Zentiva: Large European generic and specialty pharma company with deep CEE commercial presence; runs in-house sales, market access, and distribution across CEE markets where Pharmalinks also operates.

Regional players

• Medochemie: Cyprus-headquartered pharma manufacturer with established CEE and Baltic commercial operations; offers comparable in-region sales and distribution reach for third-party pharma products in CEE/Eastern Europe.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pharmalinks